Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Gland Pharma: What Should You Do?
Gland Pharma: What Should You Do?
BusinessLine

Gland pharma is primarily a generic injectables manufacturing and CDMO (Contract Development and Manufacturing Outsourcing) company. Its growth will be driven by base operations and recovery in acquired operations. The company has established a…

marketbeat.com - Candriam S.C.A. Acquires 43,338 Shares of Ascendis Pharma A/S $ASND
Candriam S.C.A. Acquires 43,338 Shares of Ascendis Pharma A/S $ASND
MarketBeat

Candriam S.C.A. grew its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 23.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned…

techcrunch.com - Connie Loizos - Reed Jobs would rather talk about curing cancer than his last name
Reed Jobs would rather talk about curing cancer than his last name
TechCrunch

Reed Jobs is easy to like. He's motormouthed, self-deprecating, prone to video-game analogies, and clearly loves his work. He doesn't particularly want to discuss the fact that he is Steve Jobs's son, but he's not uptight about it, either. When our…

cnbc.com - Annika Kim Constantino - A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
CNBC

Vivani Medical believes a tiny implant placed under the skin could help address the biggest issue with blockbuster GLP-1s: keeping patients on treatment to maintain their weight loss. The biotech company is in the early stages of developing an…

afaqs.com - afaqs! news bureau - Former JioStar executive Vishal Sharma joins J Brrothers as India head
Former JioStar executive Vishal Sharma joins J Brrothers as India head
afaqs!

US-based J Brrothers LLC has appointed Vishal N. Sharma as head of India operations. In the new role, he will oversee the company's operations in India and support its global expansion plans. Sharma joins the company after a seven-year stint at…

news-medical.net - Harvard University hosts the world's largest conference dedicated to longevity biotechnology
Harvard University hosts the world's largest conference dedicated to longevity biotechnology
News-Medical

The 13 Aging Research & Drug Discovery (ARDD) Meeting, the world's largest conference dedicated to longevity biotechnology, will take place from October 1-3, 2026, at the David Rubenstein Treehouse at Harvard University. Marking the high-profile…

cnbc.com - Elsa Ohlen - AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?
CNBC

AstraZeneca posted a rare clinical trial failure on Thursday, sending shares down 6% to their worst day in over two years. Analysts estimate the trial miss wiped just 2-4% from their valuation models but the market reaction suggested it was about…

seekingalpha.com - Albert Anthony - ARMOUR Residential REIT: A High Yield But Volatile Idea For Income Investors (NYSE:ARR)
ARMOUR Residential REIT: A High Yield But Volatile Idea For Income Investors (NYSE:ARR)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

zerohedge.com - Tyler Durden - The COVID Reckoning That Never Came
The COVID Reckoning That Never Came
Zero Hedge

Over the last several years I have been posting nonstop on X about the same nightmares we've been living through…the COVID psyop, the experimental mRNA shots, the mandates that destroyed lives, the injuries, the excess deaths, and the…

thehindubusinessline.com - Simply Put: FDA Inspections
Simply Put: FDA Inspections
BusinessLine

Leo and Emraan meet in the office cafeteria over a cup of coffee, and the discussion moves from football to US FDA at a surprising pace. Leo: Hey, did you see the match yesterday? Argentina won like I said. Emraan: The player made a foul and should…

fool.com - Keith Speights - Should You Buy Eli Lilly Stock? Here's My Honest Take.
Should You Buy Eli Lilly Stock? Here's My Honest Take.
The Motley Fool

Eli Lilly (LLY 2.30%) is in a league of its own. It's the largest healthcare company in the world by market cap, with the No. 2 company (Johnson & Johnson (JNJ 0.82%)) barely over half as big. Lilly's shares have more than quintupled in value over…

marketbeat.com - Equitable Trust Co. Invests $2.59 Million in Teva Pharmaceutical Industries Ltd. $TEVA
Equitable Trust Co. Invests $2.59 Million in Teva Pharmaceutical Industries Ltd. $TEVA
MarketBeat

Equitable Trust Co. purchased a new stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 85,895 shares of the company's stock…

dailymail.com - Holly Mackay - This dirty little money secret has made me £9,000 so far this year
This dirty little money secret has made me £9,000 so far this year
Mail Online

This year I have broken the golden rules of investing I've lived by since entering the world of finance nearly 30 years ago. With most of my savings I continue to invest sensibly for the long term, buying and holding for decades rather than days…

marketbeat.com - Top Pharmaceutical Stocks To Follow Today - July 11th
Top Pharmaceutical Stocks To Follow Today - July 11th
MarketBeat

As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner Eli Lilly and Company, AbbVie, Gilead Sciences, Alnylam Pharmaceuticals, Vertex Pharmaceuticals, Ionis Pharmaceuticals, and Pfizer are the seven Pharmaceutical stocks to watch…

marketbeat.com - Money Concepts Capital Corp Lowers Stake in Astrazeneca Plc $AZN
Money Concepts Capital Corp Lowers Stake in Astrazeneca Plc $AZN
MarketBeat

Money Concepts Capital Corp cut its holdings in Astrazeneca Plc (NYSE:AZN - Free Report) by 51.8% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,801 shares of the company's…

Receive a Daily briefing on Pharma Industry News

Get Started